Avid Bioservices Inc (CDMO)

[biopharm]

Wook, I did not realize/forgot the problem a free IHUB membership can create. I have solved the problem here....Bio_Researcher said on AZN board late afternoon Friday, 12-01-2017, in a message to me:

"North40K- This is an older post of yours (March 2017 I think), however I wanted to thank you for your exceptional efforts with this....

Quote:
'Several AZN-based tweets from attendees at the SGO convention[in suburban Washington, D.C.] the past few days suggested that there is a need for an early detection and diagnostic means for ovarian cancer...patients in later stages of ovarian cancer have not survived well, if at all. Patriots owner, Robert Kraft's wife died of ovarian cancer some 5-6 years ago:

http://insider.foxnews.com/2017/02/03/robert-kraft-donald-trump-friendship-super-bowl

'The content of the following links suggests there is a proof-of-concept solution to that problem, from researchers at UTSW, that is not yet widely known---it is based on "exosome" technology:

http://www.exosome-rna.com/proof-of-concept-data-for-a-novel-exosome-based-cancer-detection-platform-published/
[color=red]See the Abstract, Introduction, and description[note the reference to 100% accuracy in ability to distinguish active tumor cells from benign cells from normal cells present in a blood sample][/color] accompanying fig.4 of the above referenced article set forth here:

http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=14795&path%5B%5D=47251

'All cancers might be detected and diagnosed using the blood sampling means/technique described above, according to the UTSW researchers:

http://www.utsouthwestern.edu/edumedia/edufiles/about_us/admin_offices/technology_development/available_technologies/utsd-2932.pdf

'See particularly Table 1 and Examples 6-8 of the authors' published patent application:

http://tinyurl.com/gqvwkga

'Previously, I had sent[February 2017] the gist of the above to 1) the Bidens at their foundation, 2)Joy Drake at OCRFA.org, for distribution to colleagues at the Ovarian Cancer Research Fund Alliance, 3) Dr.Jon LaPook at CBS news, 4) contacts I have at BMGF, 5) Dr. Jedd Wolchok at MSKCC and a few others. I interspersed my comments as appropriate to each of above. I have met and talked with Dr. Wolchok previously at his Wistar lecture in Philadelphia in early December 2016.

'My purposes: to try to create publicity, and perhaps funding, to bring the proof-of-concept research of Dr. Schroit et al at UTSW 1) to any fruition, and 2) to the attention of members of the public that might be interested. I have no idea whether/if/when those purposes have been, or will be, fulfilled.'

*************
Private Reply | Keep | Public Reply | View Replies (1) | Mark as Last Read

north40000 Member Profile north40000 Member Level Friday, December 1, 2017 5:50:39 PM
Re: biotech_researcher post# 115 Post # 116 of 117

'Glad you found that useful, biotech_researcher......there is now further, later info on PPHM IHub message board in the yellow stickies under exosome update. Can’t post a link from IPhone. I was thinking of AZN’s Durvalumab when I put the original post on AZN message board'

***********
Private Reply | Keep | Public Reply | View Replies (1) | Mark as Last Read

biopharm Member Profile biopharm Saturday, December 2,2017 7:07:36 AM
Re: north40000 post# 116 Post #117 of 117

'Sounds like AstraZeneca will certainly require a license from a portion of the IP from Peregrine Pharmaceuticals PPHM and hopefully this attracts more immediate attention to the uses of PS Targeting ..

Thanks for your original post in sending out all information to the listed parties'

*******************

The Board of Directors at Peregrine Pharmaceuticals, now CDMO....are not responding back with any requests pertaining to Exosomes? Fiduciary Duties seem to be silenced as well